Stockscreener 앱 받기
91.02
2.15%
-2.00
시간 외 거래:
91.02
Nuvalent Inc 주식(NUVL)의 최신 뉴스
Nuvalent: Interesting Product, But Aggressive Valuation (NASDAQ:NUVL) - Seeking Alpha
Nuvalent to present zidesamtinib patient data at lung cancer conference - Investing.com
Nuvalent unveils patient outcomes data at key cancer conference - Traders Union
Nuvalent to present zidesamtinib patient data at lung cancer conference By Investing.com - Investing.com Canada
Nuvalent (NASDAQ: NUVL) to present ARROS-1 PRO and pivotal efficacy/safety at IASLC ASCO - Stock Titan
Published on: 2025-11-04 11:51:01 - newser.com
Will Nuvalent Inc. bounce back from current support2025 Geopolitical Influence & Free Real-Time Volume Trigger Notifications - newser.com
Can Nuvalent Inc. stock maintain growth trajectoryMarket Performance Report & Free Real-Time Volume Trigger Notifications - newser.com
How Nuvalent Inc. stock trades during market volatilityMarket Growth Review & Free Reliable Trade Execution Plans - newser.com
Will Nuvalent Inc. stock rally after Fed decisionsQuarterly Portfolio Summary & Community Consensus Trade Signals - newser.com
Can volume confirm reversal in Nuvalent Inc.2025 Big Picture & Precise Entry and Exit Recommendations - newser.com
How risky is Nuvalent Inc. stock now2025 Volume Leaders & Verified Momentum Stock Watchlist - newser.com
Can Nuvalent Inc. stock outperform in 2025 bull market2025 Retail Activity & Reliable Trade Execution Plans - newser.com
Why Nuvalent Inc. stock remains resilientJuly 2025 Market Mood & Target Return Focused Picks - newser.com
What momentum indicators show for Nuvalent Inc. stockTrade Ideas & Long Hold Capital Preservation Tips - newser.com
Why analysts remain bullish on Nuvalent Inc. stockMarket Weekly Review & Momentum Based Trading Ideas - newser.com
Statistical indicators supporting Nuvalent Inc.’s strengthWall Street Watch & Technical Entry and Exit Alerts - newser.com
Published on: 2025-11-02 23:09:14 - newser.com
What data driven models say about Nuvalent Inc.’s futureTrade Analysis Summary & Daily Oversold Stock Bounce Ideas - newser.com
Using economic indicators to assess Nuvalent Inc. potentialBond Market & Real-Time Stock Price Movement Reports - newser.com
Custom strategy builders for tracking Nuvalent Inc.2025 Market Overview & Real-Time Volume Analysis - newser.com
Nuvalent, Inc. Reports Q3 2025 Progress and Financials - MSN
Barclays Maintains Nuvalent (NUVL) Overweight Recommendation - MSN
Nuvalent (NASDAQ:NUVL) Insider Deborah Ann Miller Sells 21,800 Shares - MarketBeat
Applying sector rotation models to Nuvalent Inc.Weekly Trading Summary & Pattern Based Trade Signal System - newser.com
Piper Sandler Maintains Nuvalent (NUVL) Overweight Recommendation - MSN
Analysts Have Conflicting Sentiments on These Healthcare Companies: Edwards Lifesciences (EW), Centene (CNC) and Nuvalent (NUVL) - The Globe and Mail
Nuvalent Inc Reports Q3 2025 EPS of -$1.70, Missing Estimates; S - GuruFocus
What moving averages say about Nuvalent Inc.July 2025 Update & Breakout Confirmation Trade Signals - newser.com
Nuvalent price target raised to $132 from $114 at UBS - MSN
Nuvalent price target raised to $120 from $105 at Goldman Sachs - TipRanks
Nuvalent (NASDAQ:NUVL) Announces Earnings Results - MarketBeat
Barclays Raises Price Target for Nuvalent (NUVL) to $112.00 | NU - GuruFocus
Nuvalent Executives Sell Shares Under Trading Plans - TradingView
NUVL insider trades: 4,000 options exercised, 4,000 shares sold - Stock Titan
[Form 4] Nuvalent, Inc. Insider Trading Activity - Stock Titan
UBS Adjusts Price Target on Nuvalent to $132 From $114, Maintains Buy Rating - MarketScreener
Nuvalent stock price target raised to $132 by UBS on cancer drug progress - Investing.com Canada
Analysts Are Bullish on Top Healthcare Stocks: TransMedics Group (TMDX), Nuvalent (NUVL) - The Globe and Mail
1.45%
0.86%
자본화:
|
볼륨(24시간):